About Us

Coulter Partners is a global search specialist focused exclusively on life sciences. The firm is held in the highest regard as trusted adviser to the sector on senior leadership roles in the American, U.K. and European Markets.

They have a combined expertise gained over 25 years in the industry, concentrated in the largest dedicated Life Sciences team in North America and Europe. 75 consultants work together as a single global P&L from 10 offices; 5 of these are in the US and 5 in Europe.

The firm’s approach is to hire and develop exceptional multi-skilled sector analysts with PhDs, MBAs, deep industry knowledge and an outstanding track record of search at Executive and Board level. Its team culture and personal reward system are founded on commitment to the highest standards of client and candidate service.

Their mission is to impact the industry’s ability to deliver advances in diagnosis, prevention, treatment and management of disease. They do this by bringing the world’s best talent to a broad spectrum of global clients; from multinationals, to small and midcap businesses, as well as to the global investor community, building their own teams and the boards and executive leadership of their portfolio investments.

Find a Recruiter

17

At the heart of everything they do Coulter Partners is an exceptional team of talented individuals. Multi-disciplined, passionate and committed to being the best, they have PhDs, MBAs and speak many languages. Every challenge is approached with a blend of innovative thinking and best-in-class search methodology. There are no barriers to sharing information and everyone is rewarded for quality delivery. Exchanging knowledge, experience and data brings mutual support. Success follows naturally.

Solutions And Expertise

Coulter Partners is a global search specialist focused exclusively on life sciences. The firm is held in the highest regard as trusted adviser to the sector on senior leadership roles in the American, U.K. and European Markets.

Solutions
  • Executive Search
Industries
Functions
  • CEO/President
  • Finance/Accounting
  • Human Resources
  • Marketing & Sales

News Briefings

Coulter Partners Recruits CEO for ArunA Bio

Persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies for the foreseeable future, according to Deloitte’s global sector outlook on life sciences. Navigating this new world of work requires a dramatic change in strategies for leadership, talent and human resources.

Slone Partners Places Chief Medical Officer at Goldfinch Bio

Executive search firm Slone Partners recently placed Frank Czerwiec as chief medical officer at Goldfinch Bio, a Cambridge, MA-based biotechnology company focused on discovering and developing precision medicines for the treatment of genetically-driven kidney diseases. “Goldfinch Bio is the leading life sciences and precision medicine company working passionately on kidney diseases which now affect over 800 million people

Coulter Partners Finds Chief Commercial Officer for Nanoform

Global executive search firm Coulter Partners has placed Christian Jones as chief commercial officer of Helsinki-based drug particle engineering and nanotechnology company Nanoform. Client partner Eskil Westh led the assignment. The appointment comes at a pivotal time in Nanoform’s growth, having recently completed a EUR 7 million funding round for investment in its technology and talent hiring. The

Coulter Partners Lands CEO for Biogazelle

Global executive search firm Coulter Partners has placed Armin Winands as the new CEO of Biogazelle, specialists in liquid biopsies and non-coding RNA. He succeeds co-founder Jan Hellemans, who will take on the position of chief technology officer after 10 years as CEO. Director Irene Montgomery led the assignment for Coulter Partners. Mr. Winands is a highly

Press Releases

Coulter Partners secures Vice President, Corporate Development & Strategy for Zumutor Biologics

LONDON, U.K., – Coulter Partners was delighted to partner with Zumutor Biologics, a leading Immuno-Oncology Company in the targeted NK cell therapeutics space, to secure the appointment of Ramon Valencia as Vice President, Corporate Development and Strategy. Ramon will help build on Zumutor’s key successes that include proprietary antibody discovery platforms and a compelling pipeline of

Coulter Partners secures Chief Executive Officer for Biogazelle

LONDON, U.K., – Coulter Partners was very pleased to partner with Biogazelle, specialists in liquid biopsies and non-coding RNA, to secure the appointment of Armin Winands as its new Chief Executive Officer. He follows co-founder Jan Hellemans, who will take on the role of CTO after 10 years as CEO. The appointment of Armin Winands is

Coulter Partners secures Chief Technology Officer and Vice President of Product Development for Pivot Bio

SILICON VALLEY, CA – Coulter Partners was privileged to partner recently with Pivot Bio, an agriculture technology company based in Silicon Valley, to secure the appointments of Richard Broglie, Ph.D., as Chief Technology Officer and Ernie Sanders as Vice President of Product Development. These appointments further strengthen Pivot Bio’s leadership team to help drive the development

Coulter Partners secures Chief Medical Officer for Proclara Biosciences

CAMBRIDGE, MA, January 3, 2018 – Coulter Partners was delighted to partner with Proclara Biosciences to help strengthen their leadership team with the appointment of David Michelson, M.D., as Chief Medical Officer. Proclara is a biotechnology company developing novel therapies for diseases caused by protein misfolding. Dr. Michelson joins Proclara from Merck Research Laboratories, where he served

Coulter Partners secures CEO for Stevenage Bioscience Catalyst

LONDON, UK, January 8, 2018 – Coulter Partners was pleased to partner with Stevenage Bioscience Catalyst, to help secure the appointment of Dr Sally Ann Forsyth as Chief Executive Officer. Stevenage Bioscience Catalyst (SBC), the open innovation campus driving collaboration to improve healthcare, has announced that Dr Forsyth will join as CEO in March 2018. She

Do NOT follow this link or you will be banned from the site!